期刊文献+

强的松联合普乐可复治疗V型狼疮性肾炎临床观察 被引量:1

Tacrolimus Treatment of Prednisone Combined V Lupus Nephritis Clinical Observation
下载PDF
导出
摘要 目的对V型狼疮性肾炎的强的松联合普乐可复综合治疗进行临床分析。方法选取132例V型狼疮性肾炎患者,随机分配到对照组和实验组。每组各66例。实验组采用强的松与普乐可复的综合治疗,对照组只采用普乐可复的治疗方式。利用SPSS13.0对2组的疗效进行统计学处理。结果实验组治疗效果要明显好于对照组患者,而并发症却少于对照组患者。结论对V型狼疮性肾炎患者采用强的松联合普乐可复的综合治疗要比只单独采用普乐可复治疗更加有效,更加安全。所以研究V型狼疮性肾炎的有效治疗方式是极具临床价值的。 Objective V lupus nephritis with prednisone combined therapy of tacrolimus comprehensive clinical analysis.Methods 132 patients with type V lupus nephritis were randomly assigned to the control group and experimental group.66 patients in each group.Experimental group were treated with prednisone and tacrolimus comprehensive treatment of the control group using only the treatment of tacrolimus.Using SPSS 13.0 analyze the two groups'statistics.Results The treatment significantly better than control group patients,and complications was less than control group patients.Conclusion V lupus nephritis were treated with prednisone joint comprehensive treatment of tacrolimus than solely treated with tacrolimus is more effective and more secure.So of V lupus nephritis is a very effective treatment of clinical value.
出处 《中外医疗》 2011年第21期4-4,6,共2页 China & Foreign Medical Treatment
关键词 强的松 普乐可复 V型狼疮性肾炎 Prednisone Tacrolimus V lupus nephritis
  • 相关文献

参考文献7

二级参考文献35

  • 1沈克勤,黎磊石,刘志红,张景红.环孢霉素A治疗狼疮性肾炎的临床研究[J].医学研究生学报,1991,4(2):95-98. 被引量:3
  • 2张鑫,刘志红,郑敬民,陈朝红,唐政,陈劲松,黎磊石.细胞色素P450 3A5和多药耐药基因1基因多态性在肾移植患者他克莫司血药浓度监测中的应用[J].肾脏病与透析肾移植杂志,2004,13(4):313-317. 被引量:21
  • 3[1]Hutchinson IV. The mode of action of prograf and its significance for long-term graft survival. New horizons in kidney [J]. Transplantation, 1997, 65(1):22-6. 被引量:1
  • 4[2]Laskow DA, Deierhoi MH, Hudson SH, et al. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS-61443)[J]. Transplantation, 1994,57(4):640-3. 被引量:1
  • 5[3]Mathieu P, Carrier M, White M. Conversion of cyclosporine A to tacrolimus following heart transplantation [J]. Can J Cardiol, 1999,15:1229-32. 被引量:1
  • 6[4]Kobashigawa J, Miller L, Renlund D, et al. A randomized activecontrolled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate mofetil investigators [J]. Transplantation, 1998,66(4):507-15. 被引量:1
  • 7Cameron JS. Lupus Nephritis. J Am Soc Nephrol, 1999,10(2):413-424. 被引量:1
  • 8Takada K, Illei GG, Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus 2001, 10(3):154-161. 被引量:1
  • 9Kay JE, Doe SE, Benzie CR. The mechanism of action of the immunosuppressive drug FK506. Cellular Immunol, 1989,124(1):175-181. 被引量:1
  • 10Jiang H, Yang X,Soriano RN, et al, Distinct patterns of cytokine gene suppresion by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts. Immunobiology,2000 , 202(3) :280 - 292. 被引量:1

共引文献47

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部